Onglyza
Onglyza is a medication containing Saxagliptin, primarily used to improve glycemic control in adults with type 2 diabetes. It works by inhibiting the DPP-4 enzyme, which in turn increases insulin production and decreases glucagon levels in the blood. Onglyza is typically prescribed as part of a comprehensive diabetes treatment plan that includes diet and exercise. The medication is available in tablet form and is taken once daily. It is important for patients to adhere to their prescribed regimen to achieve optimal results. Onglyza is known for its ability to help maintain steady blood sugar levels, reducing the risk of diabetes-related complications.Active substance:
SaxagliptinPharmachologic effect:
Onglyza is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones, which help to regulate blood sugar levels by increasing insulin release and decreasing glucagon levels in the blood.Indications:
- Type 2 diabetes mellitus to improve glycemic control in adults as an adjunct to diet and exercise.
Contraindications:
- Hypersensitivity to saxagliptin or any of the excipients
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
Side effects:
In order of decreasing probability: Nasopharyngitis, Headache, Upper respiratory tract infection, Urinary tract infection, Hypoglycemia, Peripheral edema, Rash
Dosing and Administration:
The recommended dose of Onglyza is 5 mg once daily, taken with or without food. For patients with moderate or severe renal impairment or end-stage renal disease, the dose is 2.5 mg once daily.
Storage:
Store at a temperature not exceeding 30°C (86°F).
Onglyza
in Cyrillic : Онглиза
SUBSTANCE
Saxagliptin
DOSAGE FORM
tablets
In Stock
available pack options :
| 5mg x 30 tablets | $82.00 |
